CCH Health Care Compliance NetNews
 
 
 

HEADLINES
Wednesday, June 16, 2010

CCH® Health Care Compliance Integrated Library
The Health Care Compliance Integrated Library delivers the latest information on health law. The Library includes seven invaluable titles:
  • Civil False Claims and Qui Tam Actions - An essential tool for bringing or defending Qui Tam action.
  • Clinical Research Compliance Manual: An Administrative Guide - Essential guidance on the laws and regulations affecting clinical research and trials.
  • Defending and Preventing Health Care Fraud and Abuse Cases: An Attorney's Guide - Clear, expert guidance on protecting against charges of health care fraud and abuse.
  • Health Care Fraud and Abuse Compliance Manual - Giving health care providers a clear perspective on fraud and abuse laws, written in plain-language.
  • Health Law and Compliance Update - Find the latest information on emerging issues. Each section is authored by an expert in the area and includes in-depth analysis of the latest health law and compliance issues.
  • Hospital Contracts Manual - Expert, current know-how in dealing with numerous hospital contract scenarios.
  • Hospital Law Manual - Health Law expertise covering treatment and payment issues in the delivery of health care services.

For more details, contact your sales rep.

The CCH HIPAA Privacy Guide June 2010 update includes:

Reimbursement Advisor
  • Requirements for the Department of Health and Human Services under the Patient Protection and Affordable Care Act (PPACA) to support the use of health information technology (HIT), including (1) integrating the respective reporting mechanisms for the Medicare Physician Quality Reporting Initiative (PQRI) and the electronic health record (EHR) meaningful use incentives no later than January 1, 2012 and (2) establishing standards and operating rules for typical electronic transactions between insurers and providers;
  • Two programs for certifying technology for EHR modules proposed by the Office of the National Coordinator (ONC) for Health Information Technology;
  • A message from the director of the ONC describing progress in establishing a Nationwide Health Information Network for exchange of health information;
  • An OCR chart summarizing key features of about 50 federal laws and regulations addressing “Confidentiality, Privacy and Security."

Learn more. Subscribers only

Not a subscriber? Subscribe today.
Receivables Report

Health Care Compliance Professional’s Manual Highlights

Endorsed by the Health Care Compliance Association, the Health Care Compliance Professional’s Manual and written by HCCA board members and other experienced compliance practitioners, provides insights on legislative and regulatory matters, offers guidance on applying the laws and regulations, and includes practical compliance solutions. Report 24 (June 2010), includes the following revised chapters:

  • “Health Care Fraud and Abuse Laws,” updated by Ritu Kaur Singh, Esq. reflects recent enforcement activities and changes to the law mandated by the Fraud Enforcement Recovery Act of 2009 and the Health Information Technology for Economics and Clinical Health Act.
  • “False Claims Act and Qui Tam Suits,” updated by Ritu Kaur Singh, Esq., reflects recent activity and changes to the law mandated by the Fraud Enforcement Recovery Act of 2009 and the Patient Protection and Affordable Care Act.
  • “An Overview of Federal Antitrust Laws and Enforcement Policies,” revised by Bevin M.B. Newman, JD., updates discussions of antitrust laws and adds recent antitrust enforcement actions related to the health care industry.
  • “Developing, Delivering, and Positioning Compliance Education and Training,” updated by Donnetta Horseman, MA, CHC, CIPP, CCE, provides additional information on training staff, including tips and examples.

Learn more. Subscribers only

Not a subscriber? Subscribe today.
Headlines

First state-specific healthcare-associated infection report available

A new report from the Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN), the first in a series, represents the first time that the CDC has reported state-specific healthcare-associated infection (HAI) information.

The initial report, titled “The First State-Specific HAI Summary Data Report,” includes both national central line-associated bloodstream infection (CLABSI) data and state-specific data for states mandated by state law to report CLABSIs. Using new data from CDC’s NHSN, the report shows an 18 percent decrease in national CLABSI incidence. It is hoped that future reports will include other infection types and data from all states.

Composite statistics used. The report presents composite statistics summarizing HAI data available from NHSN at the national and state levels. The HAI data reported are limited to CLABSIs. The CLABSI data are summarized using the Standardized Infection Ratio (SIR), a statistic used to measure the relative difference in HAI occurrence during a reporting period compared to a common referent period (i.e., standard population). The SIR can be used to track HAIs at the national, state, and local levels over time, and is closely related to the Standardized Mortality Ratio (SMR), a summary statistic widely used in public health to analyze mortality data. In HAI data analysis, the SIR compares the actual number of HAIs in a facility or state with the baseline U.S. experience (i.e., standard population), adjusting for several risk factors that have been found to be most associated with differences in infection rates.

Results. The results of the report are summarized in three tables:

  • Table 1 summarizes the variability and extent of state HAI reporting to NHSN for CLABSIs. Data were reported in 47 states and Washington, D.C. States with reporting mandates for CLABSI provided the most data; however, in many instances a large number of facilities reported data in states without mandates.
  • Table 2 displays (1) state-specific CLABSI SIRs for those states with a mandate for reporting CLABSI data, and (2) SIRs for the national aggregate data. Eleven of the 17 states with a state mandate to report CLABSI had SIRs significantly less than 1.0, while only two had SIRs significantly higher than 1.0. Nationally, among 1,538 facilities reporting CLABSI data to NHSN during the reporting period, 4,615 CLABSIs were reported. This is estimated to be 18 percent fewer than predicted, resulting in an SIR of 0.82 (95 percent CI 0.80 - 0.85).
  • Table 3 shows key percentiles within the distribution of the CLABSI SIRs calculated at the facility level within each state. During this first reporting period, in nearly all of the states with a mandate for CLABSI, at least 25 percent of healthcare facilities reported zero CLABSIs.
CDC’s First State-Specific Healthcare-Associated Infections Summary Data Report, January - June, 2009, May 27, 2010.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

Part D coverage gap discount, draft model manufacturer agreement issued

A draft model agreement to be used by the Secretary of the Department of Health and Human Services (HHS) and prescription drug manufacturers in implementing the Medicare Coverage Gap Discount Program (Discount Program) has been issued by the Centers for Medicare & Medicaid Services (CMS). Comments on the draft model agreement must be submitted to CMS by June 21, 2010.

Statutory authority. Section 3301 of the Patient Protection and Affordable Care Act (PubLNo 111-148), as amended by §1101 of the Health Care and Education Reconciliation Act of 2010 (PubLNo 111-152) (collectively known as the Affordable Care Act), established the Discount Program by adding §1860D-43 and §1860D-14A to the Social Security Act.

Program requirements. Effective January 1, 2011, the Discount Program will make manufacturer discounts available to applicable Medicare beneficiaries receiving applicable covered Part D drugs while in the coverage gap. In general, the discount on each applicable covered Part D drug is 50 percent of an amount equal to the negotiated price.

Also, beginning January 1, 2011, a Part D drug will only be covered under Part D if the manufacturer: has a signed agreement with the Secretary to participate in the Discount Program, provides applicable discounts on coverage gap claims for all of its applicable drugs, and remains in compliance with the terms of the agreement. The requirement applies to manufacturers of applicable Part D drugs. The Secretary, however, reserves the right to require all manufacturers to sign the agreement in the future if it is discovered that access to applicable Part D drugs is restricted. CMS also encourages manufacturers of non-applicable drugs to enter into an agreement if they intend to manufacture applicable Part D drugs in the future.

The new law also permits CMS to allow coverage of drugs not covered under an agreement if it determines that availability of the drug is essential to the health of beneficiaries or, for 2011 only, if there are extenuating circumstances. CMS, however, does not intend to apply this authority as it expects all manufacturers of applicable drugs to sign the agreement so that there will be no changes in the availability of coverage for Part D drugs. CMS plans to notify the public as early as possible if certain manufacturers fail to sign the agreement.

No individual revision of agreement. CMS intends to use the model manufacturer agreement as a standard agreement that will not be subject to further revision based on negotiations with individual manufacturers. The model manufacturer agreement will be finalized and posted on the CMS Web site after CMS has considered the public comments and consulted with manufacturers.

CMS Notice, 75 FR 29555, May 26, 2010, Health Care Compliance Reporter.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

Patient referral program, patient assistance program not sanctionable, OIG

The Office of Inspector General (OIG) recently concluded that neither a referral rewards program nor a patient assistance program would constitute grounds for sanctions under the civil monetary penalty provision or the exclusion authority of the Social Security Act.

Referral rewards program. An operator of several continuing care retirement communities (CCRCs) that provided housing and services to the elderly proposed a rewards program for current residents and employees. The proposed rewards program consisted of two parts: (1) gift cards to current residents and employees who recommended their community to a prospective resident, and (2) credits or rewards to current residents or employees if the prospective resident moved into independent living at the CCRC.

The OIG determined that the proposed program would have no impact on any health care professional’s decision to order a health care item or service or to refer a patient to a particular provider or supplier, and concluded that the referral program would not generate prohibited remuneration under the anti-kickback statute. The CCRC operator did not provide health care services nor did it participate in federal health care programs. When residents at the independent living level of care needed health services or items, they accessed them independently from outside providers or suppliers.

Whether an individual resident referred by a current resident or employee would actually end up needing federal health care programs at some point in the future was substantially speculative and outside the control of the current resident or employee.

Patient assistance program. A non-profit, charitable corporation operated a patient assistance program that offered financial help with co-payments to patients, including Medicare beneficiaries covered by Medicare Part B, Medicare Part D, Medicare Supplementary Health Insurance (Medigap), and Medicare Advantage.

The corporation solicited funding from donors, such as individuals and pharmaceutical manufacturers, and had absolute, independent, and autonomous discretion as to the use of the contributions within a disease fund. No donor exerted any direct or indirect influence or control over the corporation.

The OIG concluded that the program would not constitute grounds for the imposition of civil monetary penalties and that, while the program could potentially generate prohibited remuneration under the anti-kickback statute if the requisite intent to induce or reward referrals of federal health care program business were present, the OIG would not impose administrative sanctions.

OIG Advisory Opinions, Nos. 10-05 and 10-06, May 19 and 20, 2010, Health Care Compliance Reporter.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

Conviction affirmed for fraudulent billing services company

An owner of a company that provided billing services to medical providers for Medicare and other health insurance plans was properly convicted and sentenced on three counts: (1) conspiracy to defraud the U.S. and to pay and receive health care kickbacks in violation of 18 U.S.C. §371; (2) conspiracy to commit health care fraud in violation of 18 U.S.C. §1349; and (3) conspiracy to launder money in violation of 18 U.S.C. §1956(h).

Fraudulent billing scheme. One of the clients of the company was a medical clinic, which was later purchased by the owner’s close friends with the financial assistance of the owner. Prior to the sale, the medical clinic billed Medicare less than $26,000 and received slightly more than $10,000. Two weeks after the sale, the clinic billed Medicare over $262,000, and received $125,000. Patients were given cash payments known as "candy" each time they went to the clinic, regardless of whether they received treatment.

The clinic completed "superbills," which were billing forms used by providers containing patient information and diagnostic codes for submission to Medicare/Medicaid and insurance companies. The superbills always indicated that a patient received treatment, even when the patient was not treated.

Sufficiency of the evidence. Contrary to the owner’s argument, the government presented more than enough evidence to establish the owner’s convictions: the sudden increase in billing after the owner’s close friends purchased the medical clinic, and the inflated expenses listed on the superbills. Further, there was a tape recording of the owner telling an employee of the medical clinic that the clinic had paid kickbacks to patients and that the owner was behind the whole scheme.

The owner’s remaining arguments either were waived on appeal or were meritless.

U.S. v. Sotto, 11th Cir., May 26, 2010, Health Care Compliance Reporter.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

On The Front Lines

National Health Emergencies Response: Federal Statutes and Regulations, Part 2

by Patricia L. Brent, J.D., M.P.H.

This is Part 2 of a two-part article on federal statutes and regulations that allow flexibility or modification of statutory requirements for healthcare providers during times of national disasters or public health emergencies, such as the H1N1 influenza pandemic of 2009/2010. Part 1 of the article, which appeared in the June 1, 2010 issue (Vol. 13-11), discussed the National Emergencies Act (NEA), the Robert T. Stafford Disaster Relief and Emergency Assistance Act (Stafford Act), the Pandemic and All-Hazard Preparedness Act and Section 1135 waiver (§1135) of the Social Security Act.

President Obama declared the 2009 H1N1 influenza pandemic to be a national emergency under the NEA on October 23, 2009. This proclamation was aimed at providing HHS with the ability to waive certain legal requirements that might otherwise hinder the ability of our nation’s healthcare system to respond to a surge in patients that might occur as a result of the H1N1 influenza outbreak. On April 26, 2009, the acting HHS Secretary declared a public health emergency in response to the H1N1 outbreak, and HHS Secretary Sebelius renewed that declaration on July 24, 2009, and again on October 1 and December 29. The President’s proclamation, along with the declaration of a public health emergency made by the HHS Secretary, allowed for the waiver of sanctions under §1135, which were invoked on October 29, with a retroactive effect to October 23, 2009. The Secretary delegated to CMS the decisions to which requirements could be waived and for which providers. Hospitals and clinics in the affected areas where H1N1 influenza outbreaks were most prevalent during the declared public health emergency were then able to apply for a §1135 waiver if they had a demonstrable need for such.

Within a panoply of federal statutes and healthcare regulations there exists a body of coordinated policies and procedures that provide flexibility for hospitals that must respond to national health emergencies, such as the H1N1 influenza pandemic of 2009/2010, or natural disasters, such as Hurricane Katrina or the North Dakota floods of 2009 and 2010. While these regulations have specific requirements that must be met, they provide a hospital with needed options for ensuring that appropriate care can be delivered even during the most stressful of disaster events without risking normal sanctions imposed for non-compliance.

Note: Portions of this article were excerpted from Emergency Department Reimbursement Manager, 2010 Edition, Medical Learning, Inc., St. Paul, MN. Reprinted with permission.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

Not a subscriber? Subscribe today.
Search CCH Health Care
Advanced Search
Subscribe to NetNews

Receive the NetNews newsletters via e-mail and to stay up-to-date on all the latest developments.

About This Newsletter

To access the IntelliConnect™ full text documents you must be a subscriber to the Health Care Portfolio Deluxe and the Health Care Compliance Integrated Library IntelliConnect product (depending on the link).*

Links within news stories display full text documents including legislation, regulations, court decisions, rulings and government reports.

The first time you click on a link you will be taken to the IntelliConnect login page, where you will need to enter your ID and password. Subsequent links will take you directly to the desired document.

Want to Subscribe?

If you aren't a subscriber to the Health Care Portfolio Deluxe and the Health Care Compliance Integrated Library, call 800-449-9525 or let us contact you to receieve a free trial to allow you to click on the links within the news stories and see the full text documents.

You are subscribed to CCH® NetNews, sponsored by CCH. To unsubscribe or manage your newsletter preferences, go to Click Here. To subscribe, go to http://health.CCH.com/thenews.

To unsubscribe via postal mail, please contact us at: CCH, Attn: Business Compliance Marketing, 2700 Lake Cook Rd., Riverwoods, IL 60015. Please include the email address you have been contacted with.

Wolters Kluwer Law & Business is the leading provider of information covering Medicare & Medicaid, Healthcare Compliance, Food, Drug & Cosmetic Law, and Home Health. For more information about our products and services, go to http://health.cch.com/ or call 800-449-9525. This newsletter is copyrighted by CCH and may be redistributed only for non-commercial purposes and only in its entirety, specifically including the CCH headers, this paragraph and the CCH copyright line. No other redistribution or re-purposing, including but not limited to use on a web site, intranet or extranet, is permitted without prior written permission of CCH.